Substituted azaindoles as inhibitors of protein kinases, and process for their preparation

摘要

Physiologically active substituted azaindole compounds of general formula (I): compositions containing such compounds; their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs are disclosed, wherein the variables shown in formula (I) are as defined in the specification. Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases, whereby these compounds are suitable for use in the treatment of disease states capable of being modulated by the inhibition of the protein kinases.